C

Center for Biomedical Research | Knoxville, TN

Research site

Location

1415 Old Weisgarber Road, Suite 200, Knoxville, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Irinotecan

AMX0035

Pembrolizumab

Sacituzumab

Alectinib

-Clivatuzumab

CH5424802

Platinum

Paclitaxel

Atezolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

1 of 18 total trials

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surg...

Enrolling

Triple Negative Breast Cancer

Drug: Capecitabine

Drug: Sacituzumab govitecan-hziy (SG)

Trial sponsors

A

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms